Posted Nov. 8, 2013 at 12:12 p.m.

Premium Lock Oxygen Bio nets $6M from warrants, boosts cash position ahead of clinical trials

Published: 2013-11-08 12:12:16
Updated: 2013-11-08 12:12:16

Print this blog post
OxyBio OxyBio

With the exercise of those warrants, Oxygen net $6 million giving the Morrisville-based company more cash to apply toward clinical trials for levosimendan, a drug being studied to treat acute decompensated heart failure. Read more about Oxygen's plans....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll